文献速递其他结缔组织病

幼年皮肌炎的血管病变:内皮损伤、高凝状态与动脉僵硬度增加

The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness.
PubMed 文献 · Arthritis Rheumatol · 2021-05-28

结果发现患者内皮损伤标志物升高、活动期凝血酶生成增强且动脉僵硬度增加,提示持续血管损伤可能导致动脉僵硬度上升。

要点

  • 幼年皮肌炎患者循环内皮细胞计数显著高于健康对照。
  • 活动期患者微粒数量升高且以血小板和内皮来源为主。
  • 活动期凝血酶生成增强,且校正年龄后动脉僵硬度增加。

核心结论

  • 幼年皮肌炎患者存在内皮损伤增加和促炎细胞因子水平升高。
  • 微粒谱反映疾病活动状态,是血管病理、血小板活化和血栓倾向的标志物。
  • 持续的长期血管损伤可能导致幼年皮肌炎患者动脉僵硬度增加。

研究设计与样本

  • 采用免疫磁珠提取和流式细胞术分别检测循环内皮细胞和微粒。
  • 用荧光法测定血浆凝血酶生成,用脉搏波传导速度评估动脉僵硬度。

主要发现

  • 患者中位年龄10.21岁(IQR 6.68-13.40),中位病程1.63年(IQR 0.28-4.66)。
  • 所有患者循环内皮细胞计数高于对照,中位96 cells/ml(IQR 40-192)对12 cells/ml(IQR 8-24),P < 0.0001。
  • 活动期患者微粒数量高于对照,中位204.7 × 10^3/ml(IQR 87.9-412.6)对44.3 × 10^3/ml(IQR 15.0-249.1),P < 0.0001。
  • 活动期患者凝血酶生成高于非活动期患者(P = 0.0003)和对照(P < 0.0001)。
  • 校正年龄后患者颈-桡脉搏波传导速度高于对照(P = 0.003)。

临床怎么用

  • 循环内皮细胞、微粒和凝血酶生成可作为无创追踪幼年皮肌炎血管病变的候选生物标志物。
  • 微粒谱有助于区分幼年皮肌炎疾病活动状态并提示血栓倾向。
  • 脉搏波传导速度可用于评估幼年皮肌炎患者亚临床动脉僵硬度增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Vasculopathy is considered central to the pathogenesis of juvenile dermatomyositis (DM) and is associated with severe extramuscular manifestations. We undertook this study to investigate the hypothesis that the vasculopathy of juvenile DM can be noninvasively tracked by examining biomarkers of endothelial injury, subclinical inflammation, hypercoagulability, and vascular arterial stiffness. METHODS: The study population was a UK cohort of children with juvenile DM. Circulating endothelial cells (CECs) and microparticles (MPs) were identified using immunomagnetic bead extraction and flow cytometry, respectively. Plasma thrombin generation was determined using a fluorogenic assay. Cytokine and chemokine levels were measured by electrochemiluminescence. Arterial stiffness was assessed using pulse wave velocity (PWV). Results were expressed as the median and interquartile range (IQR), and statistical significance was assessed using nonparametric analyses. RESULTS: Ninety patients with juvenile DM and 79 healthy control subjects were included. The median age of the patients was 10.21 years (IQR 6.68-13.40), and the median disease duration was 1.63 years (IQR 0.28-4.66). CEC counts were higher in all patients with juvenile DM compared to controls (median 96 cells/ml [IQR (40-192] and 12 cells/ml [IQR 8-24], respectively; P < 0.0001). Circulating MP numbers were also significantly higher in patients with active juvenile DM compared to controls (median 204.7 × 103 /ml [IQR 87.9-412.6] and 44.3 × 103 /ml [IQR 15.0-249.1], respectively; P < 0.0001). MPs were predominantly of platelet and endothelial origin. Enhanced plasma thrombin generation was demonstrated in patients with active juvenile DM compared to those with inactive disease (P = 0.0003) and controls (P < 0.0001). Carotid-radial PWV adjusted for age was increased in patients with juvenile DM compared to controls (P = 0.003). CONCLUSION: We observed increased endothelial injury and increased levels of proinflammatory cytokines in patients with active juvenile DM. MP profiles reflected distinct disease activity status in juvenile DM and are markers of vascular pathology, platelet activation, and thrombotic propensity. Ongoing long-term vascular injury may result in increased arterial stiffness in patients with juvenile DM.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Papadopoulou C, Hong Y, Krol P, et al. The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness. Arthritis Rheumatol. 2021. PMID: 33393715. doi:10.1002/art.41639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。